We are live on ! Find out more
Sanders Capital

Sanders Capital Portfolio holdings

AUM $83.9B
1-Year Est. Return 37.89%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+37.89%
3 Year Est. Return
+120.64%
5 Year Est. Return
+154.21%
10 Year Est. Return
+678.77%
AUM
$46B
AUM Growth
-$3.03B
Cap. Flow
+$79.2M
Cap. Flow %
0.17%
Top 10 Hldgs %
65.9%
Holding
46
New
2
Increased
24
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$246M
2
MDT icon
Medtronic
MDT
+$178M
3
STX icon
Seagate
STX
+$127M
4
META icon
Meta Platforms (Facebook)
META
+$120M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$104M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$723M
2
SWK icon
Stanley Black & Decker
SWK
+$211M
3
DHI icon
D.R. Horton
DHI
+$136M
4
LEN icon
Lennar Class A
LEN
+$32M
5
TSM icon
TSMC
TSM
+$15.5M

Sector Composition

Rank Sector Weight
1 Technology 31.19%
2 Healthcare 26.37%
3 Communication Services 15.23%
4 Financials 7.81%
5 Consumer Staples 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKNG icon
26
Booking.com
BKNG
$149B
$358M 0.78%
3,811,200
+34,500
+0.9% +$3.22M
LEN icon
27
Lennar Class A
LEN
$20.3B
$231M 0.5%
2,941,586
-355,259
-11% -$32M
TFC icon
28
Truist Financial
TFC
$63.1B
$175M 0.38%
3,095,042
-11,290
-0.4% -$697K
APTV icon
29
Aptiv
APTV
$12.2B
$107M 0.23%
892,134
-1,710
-0.2% -$228K
NVS icon
30
Novartis
NVS
$292B
$99.7M 0.22%
+1,136,640
New +$98.4M
ABBV icon
31
AbbVie
ABBV
$434B
$95.8M 0.21%
590,688
-1,580
-0.3% -$230K
LEA icon
32
Lear
LEA
$6.42B
$84.1M 0.18%
589,510
-1,010
-0.2% -$164K
GM icon
33
General Motors
GM
$80.3B
$54.1M 0.12%
1,237,940
-8,610
-0.7% -$430K
BAC icon
34
Bank of America
BAC
$436B
$17.5M 0.04%
425,400
– –
UL icon
35
Unilever
UL
$137B
$6.87M 0.01%
133,973
-2,836
-2% -$158K
SHG icon
36
Shinhan Financial Group
SHG
$33.6B
$5.02M 0.01%
150,074
+28,980
+24% +$937K
LW icon
37
Lamb Weston
LW
$7.22B
$2.62M 0.01%
+43,800
New +$2.72M
NWG icon
38
NatWest
NWG
$77B
$2.03M ﹤0.01%
331,336
-7,521
-2% -$50.7K
ING icon
39
ING
ING
$100B
$1.45M ﹤0.01%
138,602
+1,300
+0.9% +$16.9K
SYF icon
40
Synchrony
SYF
$25.2B
$1.27M ﹤0.01%
36,640
+220
+0.6% +$9.21K
SMFG icon
41
Sumitomo Mitsui Financial
SMFG
$160B
$915K ﹤0.01%
145,963
+700
+0.5% +$4.99K
MTH icon
42
Meritage Homes
MTH
$4.7B
$799K ﹤0.01%
20,162
-80
-0.4% -$3.91K
MRK icon
43
Merck
MRK
$316B
$110K ﹤0.01%
1,344
– –
LEN.B icon
44
Lennar Class B
LEN.B
$19.9B
$104K ﹤0.01%
1,602
– –
PFE icon
45
Pfizer
PFE
$142B
– –
-12,249,376
Closed -$723M
SWK icon
46
Stanley Black & Decker
SWK
$14.7B
– –
-1,120,313
Closed -$211M
1
2

Similar funds

Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

Sanders Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Sanders Capital held 46 positions worth $46B, down 6.2% from $49B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sanders Capital's Q1 2022 filing shows 2 new, 24 increased, 15 reduced and 2 closed positions. Its largest new stake was Novartis: 1,136,640 shares worth $99.7M. The largest sale was Pfizer, an estimated $723M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • Sanders Capital's largest Q1 2022 buy was Novartis: 1,136,640 shares worth $99.7M.
  • Sanders Capital added most to Northrop Grumman in Q1 2022, an estimated $246M increase.
  • Sanders Capital's biggest Q1 2022 reduction was D.R. Horton, cutting an estimated $136M.
  • Sanders Capital fully exited Pfizer in Q1 2022, selling an estimated $723M.
  • Sanders Capital's ten largest holdings make up 66% of its $46B portfolio in Q1 2022.
  • Sanders Capital opened 2 new positions and closed 2 in Q1 2022.
  • Sanders Capital's portfolio value fell 6.2% quarter-over-quarter to $46B.

Based on Sanders Capital's 13F filing for Q1 2022, filed 20 May 2022.